Lazard Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-40,229
| Closed | -$35K | – | 2634 |
|
|
2022
Q4 | $35K | Buy |
+40,229
| New | +$35K | ﹤0.01% | 1963 |
|
|
2022
Q3 | – | Sell |
-39,498
| Closed | -$79K | – | 2635 |
|
|
2022
Q2 | $79K | Buy |
+39,498
| New | +$79K | ﹤0.01% | 1608 |
|
|
2020
Q4 | – | Sell |
-1,787
| Closed | -$19K | – | 2033 |
|
|
2020
Q3 | $19K | Sell |
1,787
-24,809
| -93% | -$264K | ﹤0.01% | 1433 |
|
|
2020
Q2 | $167K | Sell |
26,596
-2,413
| -8% | -$15.2K | ﹤0.01% | 942 |
|
|
2020
Q1 | $53K | Buy |
+29,009
| New | +$53K | ﹤0.01% | 1157 |
|